Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.22.2.2
Balance Sheet Components
 9 Months Ended
Sep. 30, 2022
Balance Sheet Components Abstract  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2021 and September 30, 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2021     2022  
             
Prepaid directors and officers liability insurance premiums   $ 821     $ 222  
Prepaid preclinical services     885       2,661  
Other     126       69  
Total   $ 1,832     $ 2,952  

 

Property, plant and equipment as of December 31, 2021 and September 30, 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2021     2022  
             
Leasehold improvements   $        15     $      15  
Furniture and fixtures     14       15  
Subtotal     29       30  
Less accumulated depreciation     (1 )     (6 )
Net   $ 28     $ 24  

 

Accounts payable as of December 31, 2021 and September 30, 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2021     2022  
             
Trade accounts payable   $      713     $ 2,216  
Credit card liability     29       76  
Total   $ 742     $ 2,292  

 

Accrued liabilities as of December 31, 2021 and September 30, 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2021     2022  
             
Accrued labor costs   $ 691     $   1,823  
Accrued drug development costs     369       1,115  
Other     152       127  
Total   $ 1,212     $ 3,065